Adrian Wiestner
MD, PhD
Senior Investigator, Hematology Branch
👥Biography 个人简介
Adrian Wiestner led early translational studies of ibrutinib in CLL at the NIH that defined its pharmacodynamic effects on lymph node signaling. His serial sampling of patients in early trials clarified mechanisms of drug action and the kinetics of disease response. He continues to investigate targeted therapies in B cell malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Adrian Wiestner 的研究动态
Follow Adrian Wiestner's research updates
留下邮箱，当我们发布与 Adrian Wiestner（National Heart, Lung, and Blood Institute (NIH)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment